Alto Neuroscience (ANRO) News Today

Alto Neuroscience, Inc. (NYSE: ANRO) stock is under pressure as multiple law firms have filed or announced investigations and class‐action lawsuits against the company. Investors face an array of compliance and securities‐fraud claims related to Alto’s IPO and subsequent disclosures, raising potential litigation costs and management distraction.

• Negative Sentiment: Faruqi & Faruqi, LLP is investigating claims on behalf of investors who suffered losses exceeding $50,000 in Alto Neuroscience and encourages them to discuss their options. SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience
• Negative Sentiment: Levi & Korsinsky, LLP urges shareholders who lost money on ANRO to join a class action suit. Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
• Negative Sentiment: The Gross Law Firm notifies shareholders of Alto Neuroscience of a securities‐law violation claim and invites contacts for possible lead plaintiff roles. Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ANRO
• Negative Sentiment: Levi & Korsinsky issues another notification about a class‐action lawsuit and upcoming filing deadline. Levi & Korsinsky Notifies Alto Neuroscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ANRO
• Negative Sentiment: Rosen Law Firm reminds purchasers of Alto’s IPO and Class Period shares of the September 19, 2025 lead‐plaintiff deadline. ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit
• Negative Sentiment: The Gross Law Firm issues an additional notice urging shareholders to contact them before September 19, 2025 to discuss rights in potential litigation. Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights – ANRO
• Negative Sentiment: Rosen Global Investor Counsel encourages Alto investors to secure counsel before the important September 19 deadline in a securities class action. ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO
• Negative Sentiment: Johnson Fistel, PLLP investigates potential fiduciary‐duty breaches by Alto officers and directors on behalf of long‐term shareholders. Johnson Fistel, PLLP Investigates Claims on Behalf of Alto Neuroscience, Inc. Long-Term Shareholders
• Negative Sentiment: Faruqi & Faruqi reminds investors of the September 19 lead‐plaintiff deadline for Alto class‐action claims. INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience
• Negative Sentiment: Pomerantz LLP announces filing of a class action against Alto Neuroscience and certain officers in the Northern District of California. Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANRO

ANRO shares have declined amid rising litigation risks and repeated reminders of lead‐plaintiff deadlines, as investors weigh potential legal exposures against Alto’s broader R&D outlook.